CH3CN and iso-propyl ether was slowly diffused into the sol-
ution to give an orange solid. Yield: 0.065 g, 30%. MP:
166–172 °C (dec). 1H NMR (500 MHz, CD3CN): δ 9.36 (4H, d,
J = 6.7 Hz), 8.98 (4H, d, J = 6.7 Hz), 8.73 (4H, d, J = 4.5 Hz),
8.70 (4H, d, J = 7.8 Hz), 8.57 (4H, s), 8.27 (4H, m), 8.00 (4H,
d, J = 8.1, 1.7 Hz), 7.87 (8H, d, J = 8.8 Hz), 7.71 (4H, d, J = 8.0
Hz), 7.52 (4H, d, J = 8.0 Hz), 7.46 (4H, dd, J = 7.8, 1.7 Hz),
6.93 (4H, d, J = 8.8 Hz), 6.84 (4H, s), 5.77 (4H, s), 5.62 (4H, s),
4.64 (8H,s) 4.14 (12H, q, J = 7.1 Hz), 4.06–4.13 (12H, m), 1.21
(8H, t, J = 7.0 Hz). ESI-MS: m/z [5⊂2e + 2OTf]2+ calcd
1221.4011, found 1221.4041.
and anomalous dispersion coefficients are contained in the
SHELXTL 5.03 program library.22 All X-ray crystal structure
graphics were created using the program DIAMOND.23
A
summary of crystal data collection, solution and structure refine-
ment parameters are listed in Table 4. Details of the X-ray struc-
ture solutions can be found in the CIF format files deposited
with the CCDC (numbers are listed in Table 4)†. This includes
any problems with crystal quality, data collection or solution
refinement that resulted in high residuals, as well as a description
of any restraints necessary to attain the chemically reasonable
models shown.
Preparation of complex [(Ru(terpy))2(5⊂2e)][OTf]8. To a sol-
ution of [5⊂2e][OTf]4 (0.030 g, 0.0109 mmol) dissolved in 1 : 1
EtOH–H2O solution was added solid [RuCl3(terpy)] (0.010 g,
0.020 mmol) and the mixture was brought to reflux for 24 h to
give a deep red solution. The reaction mixture was cooled to
room temperature and filtered through a Celite pad and washed
with EtOH until the eluent was colourless. The filtrate was then
reduced to half the volume and the addition of NaOTf produced
a red precipitate. The red solid was dissolved in CH3CN and iso-
propyl ether slowly diffused into the solution give a red solid in
Acknowledgements
The authors thank NSERC of Canada for providing funds in the
form of a Discovery Grant to S. J. L.
Notes and references
1 For reviews discussing pseudorotaxanes see: (a) T. B. Gasa, C. Valente
and J. F. Stoddart, Chem. Soc. Rev., 2011, 40, 57; (b) M. Zhang, K. Zhu
and F. Huang, Chem. Commun., 2010, 46, 8131; (c) A. Harada,
A. Hashidzume, H. Yamaguchi and Y. Takashima, Chem. Rev., 2009,
109, 5974; (d) S. K. Kim and J. L. Sessler, Chem. Soc. Rev., 2010, 39,
3784; (e) V. Balzani, G. Bergamini and P. Ceroni, Coord. Chem. Rev.,
2008, 252, 2456; (f) M. D. Lankshear and P. D. Beer, Acc. Chem. Res.,
2007, 40, 657; (g) K. Kim, Chem. Soc. Rev., 2002, 31, 96; (h) V. Balzani,
A. Credi, F. M. Raymo and J. F. Stoddart, Angew. Chem., Int. Ed., 2000,
39, 3348; (i) H. W. Gibson, in Large Ring Molecules, ed. J. A. Semlyen,
John Wiley & Sons, New York, 1996, Ch. 6, p. 191; ( j) F. M. Raymo
and J. F. Stoddart, Chem. Rev., 1999, 99, 1643.
2 For some examples of [2]pseudorotaxanes formed with DB248 see:
(a) M. Klipfel, C. Rethore, T. Muller, S. Braese and W. Klopper, Comput.
Theor. Chem., 2011, 966, 186; (b) C. Johnsen, P. C. Stein, K. A. Nielsen,
A. D. Bond and J. O. Jeppesen, Eur. J. Org. Chem., 2011, 759; (c) H.
V. Huynh, W. Sim and C. F. Chin, Dalton Trans., 2011, 40, 11690; (d) H.
W. Gibson, J. W. Jones, L. N. Zakharov, A. L. Rheingold and
C. Slebodnick, Chem.–Eur. J., 2011, 17, 3192; (e) Y. Tokunaga,
N. Wakamatsu, N. Ohiwa, O. Kimizuka, A. Ohbayashi, K. Akasaka,
S. Saeki, K. Hisada, T. Goda and Y. Shimomura, J. Org. Chem., 2010,
75, 4950; (f) Y. Suzaki, A. Takagi and K. Osakada, Chem. Lett., 2010,
39, 510; (g) M. Lee, Z. Niu, D. V. Schoonover, C. Slebodnick and H.
W. Gibson, Tetrahedron, 2010, 66, 7077; (h) J.-L. Ko, S.-H. Ueng, C.-
W. Chiu, C.-C. Lai, Y.-H. Liu, S.-M. Peng and S.-H. Chiu, Chem.–Eur.
J., 2010, 16, 6950; (i) M. A. Bolla, J. Tiburcio and S. J. Loeb, Tetrahe-
dron, 2008, 64, 8423; ( j) Y. Liu, C.-J. Li, H.-Y. Zhang, L.-H. Wang and
X.-Y. Li, Eur. J. Org. Chem., 2007, 4510; (k) D. Castillo, P. Astudillo,
J. Mares, F. J. Gonzalez, A. Vela and J. Tiburcio, Org. Biomol. Chem.,
2007, 5, 2252. For an excellent historical overview on secondary
ammonium containing pseudorotaxanes see (l) P. R. Ashton,
E. J. T. Chrystal, P. T. Glink, S. Menzer, C. Schiavo, N. Spencer, J.
F. Stoddart, P. A. Tasker, A. J. P. White and D. J. Williams, Chem.–Eur.
J., 1996, 2, 709 and references therein.
3 (a) Y. Tokunaga, T. Iwamoto, S. Nakashima, E.-I. Shoji and R. Nakata,
Tetrahedron Lett., 2011, 52, 240; (b) S. Shinoda, T. Maeda, H. Miyake
and H. Tsukube, Supramol. Chem., 2011, 23, 244; (c) D. J. Mercer, S.
J. Vella, L. Guertin, N. D. Suhan, J. Tiburcio, V. N. Vukotic, J. A. Wisner
and S. J. Loeb, Eur. J. Org. Chem., 2011, 1763; (d) Y. Tokunaga,
S. Nakashima, T. Iwamoto, K. Gambayashi, K. Hisada and T. Hoshi, Het-
erocycles, 2010, 80, 819; (e) P. G. Clark, E. N. Guidry, W. Y. Chan, W.
E. Steinmetz and R. H. Grubbs, J. Am. Chem. Soc., 2010, 132, 3405;
(f) S. Sharma, G. J. E. Davidson and S. J. Loeb, Chem. Commun., 2008,
582; (g) S. J. Loeb, J. Tiburcio, S. J. Vella and J. A. Wisner, Org.
Biomol. Chem., 2006, 4, 667; (h) G. J. E. Davidson, S. J. Loeb,
P. Passaniti, S. Silvi and A. Credi, Chem.–Eur. J., 2006, 12, 3233;
(i) V. Melnig, A. Farcas, G. Rusu and C. Baban, J. Optoelectron. Adv.
Mater., 2005, 7, 2875–2880; ( j) S. J. Loeb, J. Tiburcio and S. J. Vella,
Org. Lett., 2005, 7, 4923; (k) N. Georges, S. J. Loeb, J. Tiburcio and J.
A. Wisner, Org. Biomol. Chem., 2004, 2, 2751; (l) G. J. E. Davidson and
S. J. Loeb, Dalton Trans., 2003, 4319; (m) P. R. Ashton, R. A. Bartsch,
1
quantitative yield. H NMR (500 MHz, CD3CN): δ 9.43 (4H, d,
J = 6.4 Hz), 9.11 (4H, d, J = 6.4 Hz), 8.83 (4H, s), 8.77 (4H, d,
J = 8.1 Hz), 8.59 (4H, d, J = 8.1 Hz), 8.51 (4H, d, J = 8.1 Hz),
8.43 (4H, m), 8.42 (4H, m), 8.41 (4H, m), 8.09 (4H, d, J = 8.1
Hz), 7.93 (4H, m), 7.92 (4H, m), 7.91 (8H, m), 7.69 (4H, d, J =
8.1 Hz), 7.45 (4H, d, J = 5.2 Hz), 7.37 (4H, m, J = 5.3 Hz), 7.19
(4H, dd, J = 6.4, 6.3 Hz), 7.18 (4H, dd, J = 6.4, 6.3 Hz), 7.03
(4H, d, J = 8.7 Hz), 6.92 (4H, s), 5.87 (4H, s), 5.67 (4H, m),
4.81 (8H, s), 4.13–4.06 (12H, m), 4.13–4.06 (24H, m), 1.21
(8H, t, J = 7.0 Hz). UV-vis: λmax = 486 nm. ESI-MS: m/z [(Ru-
(terpy))2(5⊂2e) + 4OTf]4+ calcd 852.6761, found 852.6795.
Preparation of MORF [Cd(H2O)2(3b⊂2d)(3b)][BF4]6. To a
solution of 3b[BF4]2, (13 mg, 0.025 mmol) in MeNO2 (1 mL)
was added 2 equivalents of 2d (42 mg, 0.048 mmol). The result-
ing solution was stirred at room temperature for 1 h at which
time [Cd(H2O)6][BF4]2 (5 mg, 13 mmol) dissolved in MeNO2–
MeOH (0.5 mL) was added. Slow diffusion of isopropyl ether
into the MeNO2 produced yellow crystals. Yield ∼40%; deter-
mined to be a homogeneous sample by optical microscopy and
identified as having formula {[Cd(H2O)2(3b⊂2d)(3b)][BF4]6.
(MeNO2)23} by single-crystal X-ray crystallography.
Single-crystal X-ray structure determinations. Crystals were
mounted on a short glass fibre attached to a tapered copper pin.
A full hemisphere of data were collected with 30 second frames
on a Brüker APEX diffractometer fitted with a CCD based detec-
tor using MoKα radiation (0.71073 Å). Decay (<1%) was moni-
tored by 50 standard data frames measured at the beginning and
end of data collections. Diffraction data and unit-cell parameters
were consistent with the assigned space groups. Lorentzian
polarization corrections and empirical absorption corrections,
based on redundant data at varying effective azimuthal angles,
were applied to the data set. The structure was solved by direct
methods, completed by subsequent Fourier syntheses and refined
with full-matrix least-squares methods against |F2| data. All non-
hydrogen atoms were refined anisotropically. All hydrogen
atoms were treated as idealized contributions. Scattering factors
Org. Biomol. Chem.
This journal is © The Royal Society of Chemistry 2012